.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,949,527

« Back to Dashboard

Claims for Patent: 6,949,527

Title: 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
Abstract:Disclosed is a 6-mercapto-cyclodextrin derivative having a general formula (I, ) wherein m is 0-7 and n is 1-8 and m+n=7 or 8; R is (C.sub.1-6) alkylene, optionally substituted with 1-3 OH groups, or (CH.sub.2).sub.o -phenylene-CH.sub.2).sub.p --; o and p are independently 0-4; X is COOH, CONHR.sub.3, NHCOR.sub.2, SO.sub.2 OH, PO(OH).sub.2, O(CH.sub.2 --CH.sub.2 --O).sub.q --H, OH or tetrazol-5-yl: R.sub.2 is H or (C.sub.1-3)alkyl; R.sub.2 is carboxyphenyl; q is 1-3; or pharmaceutically acceptable salts thereof. The 6-mercaptocyclodextrin derivative is highly suitable for use in the reversal of drug-induced neuromuscular block.
Inventor(s): Zhang; Mingqiang (Montreal, CA), Palin; Ronald (Near Kilsyth, GB), Bennett; David Jonathan (Edinburgh, GB)
Assignee: Akzo Nobel N.V. (Arnhem, NL)
Application Number:10/603,355
Patent Claims: 1. A kit for providing neuromuscular block and its reversal comprising (a) an aminosteroidal neuromuscular blocking agent and (b) a reversal agent selected from the group consisting of 6-per-deoxy-6-per-(2-carboxyethyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(3-carboxypropyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(4-carboxyphenyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(4-carboxyphenylmethyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(2-carboxypropyl)thio-.gamma.-cyclodextrin; and 6-per-deoxy-6-per-(2-sulfoethyl)thio-.gamma.-cyclodextrin; or a pharmaceutically acceptable salt thereof.

2. A kit according to claim 1 wherein the aminosteroidal neuromuscular blocking agent is selected from the group consisting of rocuronium bromide, vecuronium bromide, pancuronium bromide, and rapacuronium bromide, or another pharmaceutically acceptable salt thereof.

3. A kit according to claim 2, wherein the neuromuscular blocking agent is rocuronium bromide and the reversal agent is 6-per-deoxy-6per-(2-carboxyethyl)thio-.gamma.-cyclodextrin sodium salt.

4. A method of treatment of a patient with a neuromuscular blocking agent comprising the steps or (a) inducing the neuromuscular block by administration of an effective amount of an aminosteroidal blocking agent selected from the group consisting of rocuronium bromide, vecuronium bromide, pancuronium bromide and rapacuronium bromide, or another pharmaceutically acceptable salt thereof, and (b) reversing the drug-induced neuromuscular block by administration of an effective amount of at least one reversal agent selected from the group consisting of 6-per-deoxy-6-per-(2-carboxyethyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(3-carboxypropyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(4-carboxyphenyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(4-carboxyphenylmethyl)thio-.gamma.-cyclodextrin; 6-per-deoxy-6-per-(2-carboxypropyl)thio-.gamma.-cyclodextrin; and 6-per-deoxy-6-per-(2-sulfoethyl)thio-.gamma.-cyclodextrin; or a pharmaceutically acceptable salt thereof.

5. The method of treatment according to claim 4, wherein the neuro-muscular blocking agent is rocuronium bromide and the reversal agent is 6-per-deoxy-6-per-(2-carboxyethyl)thio-.gamma.-cyclodextrin sodium salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc